Phase 3 Inflammatory Bowel Diseases Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Inflammatory Bowel DiseasesCrohn's DiseaseUlcerative Colitis+1 more
Eli Lilly and Company150 enrolled66 locationsNCT04844606
Recruiting
Phase 2Phase 3
Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Mostafa Bahaa50 enrolled1 locationNCT05986136
Recruiting
Phase 3
Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis
Inflammatory Bowel DiseasesUlcerative Colitis
Andreas Stallmach129 enrolled20 locationsNCT03843385
Recruiting
Phase 3
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Inflammatory Bowel DiseasesCrohn's Disease
Weill Medical College of Cornell University120 enrolled1 locationNCT06274554
Recruiting
Phase 2Phase 3
Fenofibrate in Ulcerative Colitis
Inflammatory Bowel Diseases
Tanta University60 enrolled1 locationNCT05753267